EP3853200
ERBUMINE SALT OF TREPROSTINIL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.9.2019EP published:
24.1.2024EP application number:
19773695.2
EPO information:
European Patent Register
Max expiry date:
10.9.2039
Title in English:
ERBUMINE SALT OF TREPROSTINILLanguage of the patent:
English
Timeline
Today
11.9.2019EP application
24.1.2024EP Publication
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
REMICK, David MichaelAddress:
Indianapolis, Indiana 46206-6288, US
Priority
Number:
201862732799 PDate:
18.9.2018Country:
US
Classification
Categories:
C07C 51/43, C07C 59/70, A61K 38/28, A61K 31/5575, A61P 3/10, A61P 9/08